Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 121,169 | 129,063 | 60,536 | 68,657 | 71,546 |
| Receivables | 17,763 | 11,801 | 11,864 | 10,444 | 7,344 |
| Inventories | 6,169 | 7,884 | 8,125 | 7,198 | 6,044 |
| TOTAL | $149,269 | $151,673 | $81,721 | $89,169 | $88,220 |
| Non-Current Assets | |||||
| PPE Net | 3,893 | 3,918 | 3,858 | 3,801 | 3,799 |
| Other Non-Current Assets | 7,263 | 7,968 | 8,119 | 9,264 | 9,405 |
| TOTAL | $11,156 | $11,886 | $11,977 | $13,065 | $13,204 |
| Total Assets | $160,425 | $163,559 | $93,698 | $102,234 | $101,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 39,856 | 17,192 | 15,128 | 12,307 | 10,313 |
| Accrued Expenses | 5,029 | 5,128 | 5,001 | 3,314 | 5,907 |
| Other current liabilities | 1,000 | 1,561 | 1,364 | 1,089 | 1,087 |
| TOTAL | $47,608 | $25,574 | $23,155 | $18,298 | $18,865 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,519 | 29,940 | 31,843 | 33,746 | 32,500 |
| Deferred Revenues | 1,092 | 1,092 | 1,092 | 1,048 | 1,048 |
| Other Non-Current Liabilities | 99,570 | 92,491 | 91,355 | 91,376 | 90,210 |
| TOTAL | $146,479 | $142,094 | $143,133 | $144,866 | $142,715 |
| Total Liabilities | $194,087 | $167,668 | $166,288 | $163,164 | $161,580 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 122,045 | 122,003 | 99,724 | 99,328 | 98,871 |
| Common Shares | 122 | 121 | 99 | 99 | 91 |
| Retained earnings | -446,998 | -415,138 | -399,692 | -386,144 | -363,214 |
| TOTAL | $-33,662 | $-4,109 | $-72,590 | $-60,930 | $-60,156 |
| Total Liabilities And Equity | $160,425 | $163,559 | $93,698 | $102,234 | $101,424 |